Table of Contents
Rise in incidence of diabetes across the globe has elevated the need of innovative diabetic management devices that has increased adoption of continuous glucose monitoring (CGM) devices. The existing glucose monitoring devices have few gaps which are bridged by the innovative CGM. With continuous glucose monitoring, significant improvement has been observed in stabilizing elevated A1C levels which in turn reduces risk of developing long term diabetic complications. Other driving factors for CGM market are technological innovation in the form of artificial pancreas, increasing awareness among developed, developing and under developed economies, and rise in incidences of diabetic cases. However, factors such as strict regulatory impositions, inadequate reimbursement options for CGM and accuracy as well as cost of the CGMs are restraining the market growth.The global continuous glucose monitors market generated revenue of $194.8 million in 2012 and is expected to reach market size of value $568.5 million by 2020, growing at a CAGR of 14.8% during 2013-2020. This growth is attributed to increase in technological innovations, namely launch of artificial pancreas, convenience offered by CGM over self monitoring glucose devices, and earlier detection of the hypo & hyperglycemic events by CGM.Global CGM market is segmented based on application as home settings, diagnostics and hospitals. Among all the application segments home settings is expected to generate maximum revenue by 2020.North America is the maximum revenue-generating segment across the globe, mainly due to rapid acceptance of innovative technology, well-penetrated reimbursement system when compared with other geographies and rise in patient pool. Asia Pacific is expected to grow at a faster rate due to large patient pool, geographical expansion of market players, increase in income levels and improved living standards of the people.Key market players in this market includes, Medtronics, Dexcom, Animas Corporation, Ypsomed AG, Omnipod and Miraculins, Inc inlcuding others. The major strategy adopted the market players across this geography is Collaborations, Product launches and approvals. Collaborations specifically focus on distribution and commercialization of the devices.
The report ranks the factors that are responsible to accelerate the market growth driven by upper hand of CGM over Self monitoring glucose devices, approval for artificial pancreas and many moreMarket is forecasted for period of seven years 2013 to 2020 with market revenues for 2 historic years of 20110and 2012Identification and analysis of key pockets of investment for CGM manufacturersIdentification of challenges that must be addressed and overcome in the CGM market to achieve fiscal success throughout the marketAnalysis of regulatory framework that regulates introduction of new CGM and puts light on reimbursement scenarioThe report identifies and profiles key market participants that would drive innovation in the CGM market
KEY MARKET SEGMENTS
GLOBAL MARKET, BY DEVICESTransmitter and ReceiversSensorsInsulin PumpGLOBAL MARKET, BY APPLICATIONDiagnostics/ClinicsHospitalsHome SettingsGLOBAL MARKET, BY AGEChildren and TeensYouthMiddle, Elderly and AgedGLOBAL MARKET,
North AmericaEuropeAsia PacificRow
Medical Devices ManufacturersResearch InstitutionsHealthcare Institutions
Get Industry Insights. Simply.
Talk to Ahmad
+1 718 618 4302
BRIC Glucose Monitoring Market Outlook to 2022 Summary GlobalData’s new report, "BRIC Glucose Monitoring Market Outlook to 2022", provides key market data on the BRIC Glucose Monitoring market. The report ...
North America Glucose Monitoring Market Outlook to 2022 Summary GlobalData’s new report, "North America Glucose Monitoring Market Outlook to 2022", provides key market data on the North America Glucose ...
Asia-Pacific Glucose Monitoring Market Outlook to 2022 Summary GlobalData’s new report, "Asia-Pacific Glucose Monitoring Market Outlook to 2022", provides key market data on the Asia-Pacific Glucose ...